Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the iMOST Analyzer - Matrix Study Comparing Capillary and Venous Whole Blood

NCT04778553 is registered in ClinicalTrials.gov with Essenlix Corporation as lead sponsor.

NCT NCT04778553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04778553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the iMOST Analyzer - Matrix Study Comparing Capillary and Venous Whole Blood
Lead sponsor
Essenlix Corporation
Phase
Observational
Overall status
Completed
Start date
October 19, 2020
Completion date
January 21, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic tests